| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| isradipine | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
1.87 | approved,investigational | inhibitor |
| isradipine | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
1.87 | approved,investigational | inhibitor,blocker |
| isradipine | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
1.4 | approved,investigational | inhibitor,blocker |
| isradipine | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
1.4 | approved,investigational | inhibitor |
| isradipine | voltage-dependent t-type calcium channel subunit alpha-1h | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
NA | approved,investigational | inhibitor |
| isradipine | voltage-dependent l-type calcium channel subunit alpha-1s | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
0.57 | approved,investigational | inhibitor,blocker |
| isradipine | voltage-dependent calcium channel subunit alpha-2/delta-1 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
2.53 | approved,investigational | inhibitor |
| isradipine | voltage-dependent calcium channel subunit alpha-2/delta-2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
NA | approved,investigational | inhibitor |
| isradipine | voltage-dependent l-type calcium channel subunit beta-2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Essential Hypertension[MeSHID:D000075222] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hypertensive disease[MeSHID:D006973] Herpes Simplex Infections[MeSHID:D006561] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||